MARiO: predicting cancer variant pathogenicity by integrating in silico evaluation and patient-level mutational contexts
Haruko Nakagawa, Takashi Kamatani, Naoya Ishibashi…·Sadakatsu Ikeda
MARiO predicts cancer missense variant pathogenicity by integrating variant-level features and patient-level clinical and genomic contexts, achieving high accuracy.